尼日利亚将于2026年3月启动每年的艾滋病毒预防注射。 Nigeria to launch yearly HIV prevention injectable in March 2026.

尼日利亚计划于2026年3月开始逐步推出Lenacapavir,这是一种长效注射式艾滋病毒预防药物。 Nigeria plans to begin a phased rollout of Lenacapavir, a long-acting injectable HIV prevention drug, in March 2026. 国家艾滋病控制局(NACA)确认该药物每年仅需要两剂剂量,已得到国家艾滋病控制局(NACA)的监管批准,并准备在10个优先州部署。 The National Agency for the Control of AIDS (NACA) confirmed the drug, which requires only two doses per year, has received regulatory approval from NAFDAC and is set for deployment in 10 priority states. 准备工作包括培训保健工作者、编写提高公众认识的材料以及进行准备状态评估,以确保顺利展开,作为国家努力减少新的艾滋病毒感染工作的一部分。 Preparations include training healthcare workers, developing public awareness materials, and readiness assessments to ensure a smooth rollout as part of national efforts to reduce new HIV infections.